FDA Approves Wegovy, a High-Dose Version of the Diabetes Drug Semaglutide for Use as Aid to Weight Loss
Wegovy -- a high-dose version of the diabetes drug semaglutide -- has been approved as a new aid to weight loss by the U.S. Food and Drug Administration. Studies funded by drug maker Novo Nordisk showed that participants who received weekly...